Veeva Systems Inc. logo

Veeva Systems Inc. (VEEV)

Market Closed
4 Jun, 20:00
NYSE NYSE
$
178. 60
-0.12
-0.0671%
$
30.78B Market Cap
51.77 P/E Ratio
- Div Yield
3.62M Volume
4.18 Eps
$ 178.72
Previous Close
Add Transaction
Day Range
174.63 185.48
Year Range
148.05 310.5
Want to track VEEV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts

Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts

Veeva Systems (VEEV) concluded the recent trading session at $203.89, signifying a -0.34% move from its prior day's close.

Zacks | 2 years ago
Veeva (VEEV) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Veeva (VEEV) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Get a deeper insight into the potential performance of Veeva (VEEV) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 2 years ago
Veeva Systems (VEEV) Stock Drops Despite Market Gains: Important Facts to Note

Veeva Systems (VEEV) Stock Drops Despite Market Gains: Important Facts to Note

Veeva Systems (VEEV) closed the most recent trading day at $209.24, moving -0.34% from the previous trading session.

Zacks | 2 years ago
Janney Montgomery Scott LLC Lowers Stock Position in Veeva Systems Inc. (NYSE:VEEV)

Janney Montgomery Scott LLC Lowers Stock Position in Veeva Systems Inc. (NYSE:VEEV)

Janney Montgomery Scott LLC cut its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 25.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,305 shares of the technology company’s stock after selling 13,480 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Veeva Systems were worth $7,567,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewEdge Wealth LLC increased its position in Veeva Systems by 0.6% during the third quarter. NewEdge Wealth LLC now owns 10,059 shares of the technology company’s stock worth $2,047,000 after buying an additional 60 shares in the last quarter. Yousif Capital Management LLC lifted its stake in shares of Veeva Systems by 3.5% during the fourth quarter. Yousif Capital Management LLC now owns 1,777 shares of the technology company’s stock valued at $342,000 after buying an additional 60 shares during the period. Personal CFO Solutions LLC boosted its position in Veeva Systems by 5.9% during the third quarter. Personal CFO Solutions LLC now owns 1,091 shares of the technology company’s stock worth $222,000 after acquiring an additional 61 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in Veeva Systems by 3.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,940 shares of the technology company’s stock worth $395,000 after acquiring an additional 63 shares during the period. Finally, Cape Investment Advisory Inc. raised its holdings in Veeva Systems by 3.0% in the 3rd quarter. Cape Investment Advisory Inc. now owns 2,180 shares of the technology company’s stock valued at $444,000 after acquiring an additional 64 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock. Analyst Ratings Changes Several equities research analysts have recently issued reports on VEEV shares. Jefferies Financial Group raised their price objective on Veeva Systems from $225.00 to $270.00 and gave the stock a “buy” rating in a report on Monday, March 4th. JPMorgan Chase & Co. raised their price target on Veeva Systems from $183.00 to $222.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 13th. Barclays upped their price objective on shares of Veeva Systems from $240.00 to $245.00 and gave the company an “overweight” rating in a research note on Friday, March 1st. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research report on Friday, April 12th. Finally, Raymond James reaffirmed an “outperform” rating and set a $260.00 price target on shares of Veeva Systems in a research report on Tuesday, March 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Veeva Systems has an average rating of “Moderate Buy” and an average target price of $234.90. Check Out Our Latest Research Report on Veeva Systems Veeva Systems Stock Performance Veeva Systems stock opened at $210.27 on Monday. The stock’s 50 day moving average price is $213.53 and its 200 day moving average price is $202.90. Veeva Systems Inc. has a one year low of $160.21 and a one year high of $236.90. The firm has a market capitalization of $33.92 billion, a PE ratio of 65.30, a price-to-earnings-growth ratio of 2.13 and a beta of 0.76. Veeva Systems (NYSE:VEEV – Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The technology company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.81 by $0.11. Veeva Systems had a return on equity of 11.26% and a net margin of 22.24%. The firm had revenue of $630.62 million during the quarter, compared to the consensus estimate of $620.75 million. On average, analysts forecast that Veeva Systems Inc. will post 4.11 earnings per share for the current fiscal year. Insider Transactions at Veeva Systems In other Veeva Systems news, Director Timothy S. Cabral sold 15,000 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the completion of the sale, the director now owns 23,391 shares in the company, valued at $5,287,301.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Jonathan Faddis sold 3,598 shares of the company’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $207.42, for a total transaction of $746,297.16. Following the completion of the transaction, the senior vice president now owns 10,668 shares in the company, valued at $2,212,756.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy S. Cabral sold 15,000 shares of the business’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the transaction, the director now directly owns 23,391 shares of the company’s stock, valued at $5,287,301.64. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 21,989 shares of company stock valued at $4,818,013. Insiders own 10.50% of the company’s stock. Veeva Systems Profile (Free Report) Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. See Also Five stocks we like better than Veeva Systems What is MarketRank? How to Use it Canada Goose Flies Higher Driven By DTC Growth REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today CVS Health Stock Has a Silver Lining Called Value Why Invest in High-Yield Dividend Stocks? Magnificent 7 Still Magnificent as the Halfway Mark Approaches?

Defenseworld | 2 years ago
Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs

Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs

Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.

Zacks | 2 years ago